Jamol Laboratories, Inc.

Form 483 issued January 12, 2023 · Emerson, New Jersey

Inspection
Dec 5, 2022 – Jan 12, 2023
Observations
4
Pages
5
FEI number
2211383

In short: On January 12, 2023, FDA issued a Form 483 with 4 observations to Jamol Laboratories, Inc. in Emerson, New Jersey (FEI 2211383) after an inspection that ran Dec 5, 2022 – Jan 12, 2023. The investigator was Jessica S. Estriplet. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 3 of 4 observations.

Production2
Facilities & equipment1
Quality system1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Your firm failed to establish written procedures for production and process controls designed to assure that…

  2. 02

    Buildings used in the manufacture, processing, packing, or holding of a drug product do not have…

  3. 03

    Written records are not always made of…

  4. 04

    Batch production and control records do not include complete information relating to the production and…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Jamol Laboratories, Inc.?

FDA listed 4 observations on this Form 483, mostly about production, facilities & equipment and quality system. The opening words of each observation are shown on this page.

Who inspected Jamol Laboratories, Inc.?

Jessica S. Estriplet is named on this Form 483, for the inspection of Dec 5, 2022 – Jan 12, 2023. Each investigator has a profile showing what they cite most.

When was Jamol Laboratories, Inc. inspected by FDA?

The inspection ran Dec 5, 2022 – Jan 12, 2023, and the Form 483 is dated January 12, 2023.

How do I get the full Form 483 for Jamol Laboratories, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free